SlideShare a Scribd company logo
1
Hypertensive disorders of
pregnancy
Prof. Adel Abul-Heija
2
Introduction
1. Hypertensive disorders of pregnancy are
one of the leading causes of maternal
mortality.
2. Worldwide: 50,000 women die each year.
3. Jordan: 4th. Cause of maternal death after
(hemorrhage, thrombo-embolism, and
sepsis. (Jordan MMR 19.1 per 100000 live
birth, 2007-2008)
3
Diagnosis of hypertension in
pregnancy
 A systolic BP of > 140 mmHg, a diastolic BP
of > 90 mmHg, or both.
 Hypertension is considered severe when BP >
160 for systolic or > 110 for diastolic.
 It required at lest two determinations with at
least 6 hours apart of bed rest.
4
How to measure BP in pregnant
woman
 Women should be allowed to sit quietly for 10-20 minutes before
each blood pressure measurement.
 Blood pressure should be measured in the sitting position, with the
cuff at the level of the heart.
 Korotkoff sounds I (the first sound) and V (the disappearance of
sound) should be used to denote the systolic blood pressure
(SBP) and DBP, respectively.
 In about 5% of women, an exaggerated gap exists between the
fourth (muffling) and fifth (disappearance) Korotkoff sounds, with
the fifth sound approaching zero. In this setting, both the fourth
and fifth sounds should be recorded (eg, 120/80/40, with sound I =
120, sound IV = 80, and sound V = 40), because the fourth sound
will more closely approximate the true DBP.
5
Diagnosis of Protienurea in
pregnancy
 Proteinuria:
 ≥ 300mg/24 hours urine.
 ≥ +1 dipstick. (only applicable if the others are not
avialables)
 Urinary Protein:creatinine ratio:
 At least 0.3 (each measured as mg/dl)
6
Classifications
 Gestational hypertension.
 Preeclampsia-Eclampsia.
 Chronic hypertension with pregnancy.
 Chronic hypertension with
Superimposed preeclampsia.
7
Definitions
 Gestational hypertension:
– Hypertension for first time after 20 w, without
Proteinuria. BP returns to normal before 12
weeks postpartum.
 Chronic hypertension with pregnancy:
– Hypertension antedates pregnancy and detected
before 20 w, & lasts more than 12 weeks
postpartum.
8
Definitions
– Preeclampsia:
 The development of hypertension and Proteinuria after
20 weeks.
 May occur earlier in vesicular mole or multiple
pregnancy.
 Preeclampsia is diagnosed also in the presence of
sever features even in the absence of protienurea (see
next slide).
– Eclampsia:
 The occurrence of tonic-clonic convulsions (without
any neurological disease) in a woman with pre-
eclampsia.
9
Definitions
 Superimposed pre-eclampsia:
¤ It is the new development of Proteinuria
after 20 weeks gestation in a patient with
chronic hypertension
10
11
Incidence of hypertensive disorders in
pregnancy
 Gestational hypertension occurs in around 5-6% of all
pregnancies. More common in primigravida. Most cases are
diagnosed after 34 weeks.
 PE complicates 1-2% of all pregnancies. 4-7% of first
pregnancies (1 in 4 of PIH) and 1% of subsequent
pregnancies, rising to 16% with history of preeclampsia in
first pregnancy.
 Around 5-10% of PE cases are severe.
 Approximately 1% of pregnancies are complicated by
chronic hypertension and 20-25% of women with chronic
hypertension develop preeclampsia during pregnancy.
12
Pre-eclampsia (PE):
Definition:
A diastolic BP > 90 mmHg, on at least two
occasions after 20 weeks of gestation
accompanied by significant proteinuria (>
300 mg/24h) and/or other systemic severe
manifestations mentioned before.
13
Aetiology of PE:
PE is the disease of theories:
1. Damage to the vascular endothelial cells.
2. Abnormal lipid metabolism.
3. Reduced anti-oxidant status.
4. Altered catecholamine homeostasis.
5. Abnormal dietary calcium, magnesium, or selenium.
6. Reduced production of nitric oxide.
7. Abnormal immune response to pregnancy.
14
Patho-physiology of PE:
 Abnormal placentation is central to the pathogenesis
of PE.
 In PE there is reduction in the synthesis of nitric
oxide and prostacyclin and increased production of
endothelin and sensitivity to angiotensin. This result
in to vasospasm and endothelial dysfunction, with
subsequent platelet activation and micro thrombus
formation. These are responsible for features of PE.
15
Multi-system Features Of
Preeclampsia
Multi-organ disease
Kidney
Systemic blood vessels
Liver
Fetus
Cerebral blood vessels
HELLP syndrome
IUGR
Eclampsia
Proteinuria
Hypertension
16
Clinical features of PE:
Maternal syndrome:
1. PIH.
2. Proteinuria.
3. Generalized oedema.
4. Hyperuricaemia.
5. Increased haematocrit.
6. Thrombocytopenia & DIC.
7. Reduced antithrombin III.
8. Abnormal liver function tests.
9. Hypocalciuria.
10. Seizures, cortical blindness,
retinal detachment (eclampsia).
Fetal syndrome:
1. IUGR.
2. Fetal hypoxaemia.
17
Prevention of PE:
 Aspirin: Low dose (81mg/day) increases the
prostacycline to thromboxan ratio and prevent platelets
aggregation. It should be used from 12 weeks of
pregnancy in women at risk.
 Calcium supplementation ( may reduce severity in
women with low intake of calcium.
 Antioxidant: vit.C or vit.E (not effective)
 Restriction of dietary salt (not effective)
18
High risk women that need aspirin
 Maternal disorders:
– Chronic hypertension
– Renal diseases
– Diabetes
– Autoimmune conditions
 First pregnancy
 Multiple pregnancy
 Maternal BMI > 25
 H/O preeclampsia
 Age > 40 years
19
Investigations for PE:
 Urinalysis.
 24 h urine collection for total protein.
 Renal function (urea,uric acid,s. creatinine).
 Full blood count (platelets and haematocrit).
 Liver function tests.
 Coagulation profile if delivery is indicated.
 Fetal biophysical profile and Doppler study.
20
Management of PE:
 Diagnosis of PE requires admission for bed
rest and close monitoring for mother and fetus.
 If the diastolic BP is 90-95mmHg with only 1+
protein in the urine, out-patient management
could be followed.
 The definitive treatment for PE is delivery. But
this depend on gestational age and feto-
maternal well-being.
21
Management of PE (cont.):
Antihypertensive therapy:
 Treating the hypertension is mainly to reduce the maternal
complications. It will not improve fetal condition.
Acute treatment of severe hypertension:
 Hydralazine: 5mg IV repeated every 20-30 min.
 Nifedipine: 10mg orally repeated at 30 min. IV infusion can be
used in severe cases.
 Labetalol:10-20mg IV .
 The dose can be doubled every 10 minutes if proper
response is not achieved.
 Magnesium Sulphate should be given in the management of
all cases of severe preeclampsia to prevent eclampsia.
22
Indications for delivery in PE:
 Term pregnancy.
 Severe uncontrolled hypertension (>160/110).
 Haemolysis with thrombocytopenia.
 Progressive symptoms (headache, visual disturbances,
epigastric pain).
 Pulmonary oedema.
 Renal failure with oliguria.
 Eclampsia.
 Fetal compromise ( abnormal biophysical profile).
23
Management of labour and
delivery:
 The mode of delivery is determined by Bishop’s score
and feto-maternal well-being.
 Induction of labour is commonly used, but CS is
needed in large number of cases.
 Fluids input and output should be monitored.
 Prolonged pushing by the mother should be avoided.
 Ergometrine should be avoided.
 Pain relief is optimal (epidural analgesia if no signs of
DIC).
24
Complications of severe PE:
Eclampsia: Occurrence of convulsions in association with
PE.
 Incidence: 5 in 10 000 deliveries and 1-2% of severe
PE cases.
 High maternal and fetal mortality.
 It can occur ante-natally, intra-partum and post-partum.
 The patho-physiology is cerebral vasospasm leading to
ischemia and cerebral edema.
25
Eclampsia:
Diagnosis:
 Women manifest excitability or hyperflexia prior
to onset of seizure.
 Tonic-clonic convulsions with small period of
coma.
 Prolonged coma mains CVA.
26
Management of eclampsia:
 During seizure: Maintain airway, Administer oxygen
and avoid supine hypotension.
 Anticonvulsant therapy:
1. Magnesium sulphate 4-6 g IV followed by a
maintenance infusion of 1-2 g / h.
2. Diazepam 20mg IV followed by a maintenance
infusion as required.
3. Phynenton
 Anticonvulsant should be continued for at least 24 h
after the last convulsion.
 CS is indicated unless the mother is in active labour.
27
Magnesium Sulfate (MgSO4):
 It can be given IV or IM or SC
– The therapeutic level is 4-7mEq/L.
– The total dose of MgSO4 should not exceed 24 gms in 24
hours .
 The dose of MgSO4 is monitored by:
 Preserved patellar reflex. (7-10 mEq/L)
 Respiratory rate >16/min. (10-13 mEq/L)
 Urine output >100ml/4hours. (15-25 mEq/L)
 Serum Mg++ level.
 Is stopped 24 hours after delivery.
 Antidote is ca gluconate
28
Complications of severe PE:
HELLP syndrome: Occurs in the absence of hypertension.
H: haemolysis.
EL: elevated liver enzymes.
LP: low platelet count.
 Present with epigastric pain, tender liver, nausea & vomiting.
 Headache and arterial hypertension.
 Carries high maternal (acute renal failure & pulmonary odema)
and fetal mortality.
 Treatment similar to eclampia & DIC. Platelet transfusion and
cortico-steroids are necessary.
 Delivery is the treatment of choice.
29
Chronic hypertension in pregnancy
Causes of CHT:
1. Essential hypertension.
2. Renal diseases (glomerulonephritis, polycystic
disease, diabetic nephropathy, renal artery stenosis).
3. Collagen vascular diseases ( systemic lupus
erythematosus, scleroderma).
4. Coarctation of the aorta.
5. Phaeochromocytoma.
30
Chronic hypertension in pregnancy
 The main concern that one third of these women will
develop superimposed PIH.
Risk factors for preeclampsia in CHT:
1. Renal disease.
2. Maternal age > 40 years.
3. Diabetes.
4. SLE.
5. Coarctation of the aorta.
6. BP > 160/100 mmHg in early pregnancy.
31
Chronic hypertension in pregnancy
Feto-Maternal risks:
1. Eclampsia.
2. Abruptio-placenta.
3. Heart failure.
4. Intracerebral haemorrhage.
5. IUGR.
32
Long-term treatment of hypertension
This is used mainly in CHD.
 Methyldopa is the most common in use (least
side effects). 1-2 g / day in three divided doses.
 Nifedipine 40 mg / day in two divided doses.
 Labetolol and Hydralazine can also be used.
 ACE inhibitors, Angiotensin II blocker, and
Chlorothiazide should be avoided because of
teratogenic effect.
33
Chronic hypertension in pregnancy
Management:
 Investigations should be performed to diagnose the
cause of hypertension.
 If the woman is on antihypertensive drugs, she should
continue on it, except for angiotensin converting
enzyme inhibitors (captoprel) because of risk of fetal
damage. Care should be taken not to excessively
lower the BP as this may affect the fetal healthy.
 Maternal and fetal well-being should be monitored
through the pregnancy.
34
Chronic hypertension in pregnancy
Management (cont.):
 In severe cases admission is needed.
 The obstetric management is similar to that of
preeclampsia.
 Timing the delivery must be individualized
according to the feto-maternal well-being.
 Induction of labour or CS should be selected
according to the case.
35

More Related Content

What's hot

Cholestasis of pregnancy
Cholestasis of pregnancyCholestasis of pregnancy
Cholestasis of pregnancy
nishma bajracharya
 
Postpartum Haemorrhage
Postpartum HaemorrhagePostpartum Haemorrhage
Postpartum Haemorrhage
Fadhli Karim
 
Physiological changes during pregnancy
Physiological changes during pregnancyPhysiological changes during pregnancy
Physiological changes during pregnancy
Sai Sandeep
 
EPILEPSY AND PREGNANCY
EPILEPSY AND PREGNANCYEPILEPSY AND PREGNANCY
EPILEPSY AND PREGNANCY
Aboubakr Elnashar
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
Dr.Laxmi Agrawal Shrikhande
 
Ventose and forceps delivery for undergraduate
Ventose and forceps delivery for undergraduateVentose and forceps delivery for undergraduate
Ventose and forceps delivery for undergraduate
Faculty of Medicine,Zagazig University,EGYPT
 
Physiological changes in pregnancy
Physiological changes in pregnancyPhysiological changes in pregnancy
Physiological changes in pregnancy
Nandinii Ramasenderan
 
Intrapartum fetal monitoring for undergraduate
Intrapartum fetal monitoring for undergraduateIntrapartum fetal monitoring for undergraduate
Intrapartum fetal monitoring for undergraduate
Faculty of Medicine,Zagazig University,EGYPT
 
Systemic lupus erythematosus During pregnancy
Systemic lupus erythematosus During pregnancySystemic lupus erythematosus During pregnancy
Systemic lupus erythematosus During pregnancy
Aboubakr Elnashar
 
Pih ppt
Pih pptPih ppt
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
faheta
 
Antepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringAntepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoring
rajeev sood
 
Hypertensive disorders in Pregnancy
Hypertensive disorders in PregnancyHypertensive disorders in Pregnancy
Hypertensive disorders in Pregnancy
Tasbeeh ur Rahman
 
Pre eclampsia geet 11
Pre eclampsia geet 11Pre eclampsia geet 11
Pre eclampsia geet 11
Gitanjali Kumari
 
Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Hypertensive disorders in pregnancy recent guidelines fogsi 2014Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Dr Meenakshi Sharma
 
Newer Predictors of Preeclampsia
Newer Predictors of PreeclampsiaNewer Predictors of Preeclampsia
Newer Predictors of Preeclampsia
Dr Anusha Rao P
 
Preeclampsia
PreeclampsiaPreeclampsia
Induction of Labour
Induction of LabourInduction of Labour
Induction of Labour
limgengyan
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
doctorshazly
 
Pph
PphPph

What's hot (20)

Cholestasis of pregnancy
Cholestasis of pregnancyCholestasis of pregnancy
Cholestasis of pregnancy
 
Postpartum Haemorrhage
Postpartum HaemorrhagePostpartum Haemorrhage
Postpartum Haemorrhage
 
Physiological changes during pregnancy
Physiological changes during pregnancyPhysiological changes during pregnancy
Physiological changes during pregnancy
 
EPILEPSY AND PREGNANCY
EPILEPSY AND PREGNANCYEPILEPSY AND PREGNANCY
EPILEPSY AND PREGNANCY
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
 
Ventose and forceps delivery for undergraduate
Ventose and forceps delivery for undergraduateVentose and forceps delivery for undergraduate
Ventose and forceps delivery for undergraduate
 
Physiological changes in pregnancy
Physiological changes in pregnancyPhysiological changes in pregnancy
Physiological changes in pregnancy
 
Intrapartum fetal monitoring for undergraduate
Intrapartum fetal monitoring for undergraduateIntrapartum fetal monitoring for undergraduate
Intrapartum fetal monitoring for undergraduate
 
Systemic lupus erythematosus During pregnancy
Systemic lupus erythematosus During pregnancySystemic lupus erythematosus During pregnancy
Systemic lupus erythematosus During pregnancy
 
Pih ppt
Pih pptPih ppt
Pih ppt
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
 
Antepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringAntepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoring
 
Hypertensive disorders in Pregnancy
Hypertensive disorders in PregnancyHypertensive disorders in Pregnancy
Hypertensive disorders in Pregnancy
 
Pre eclampsia geet 11
Pre eclampsia geet 11Pre eclampsia geet 11
Pre eclampsia geet 11
 
Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Hypertensive disorders in pregnancy recent guidelines fogsi 2014Hypertensive disorders in pregnancy recent guidelines fogsi 2014
Hypertensive disorders in pregnancy recent guidelines fogsi 2014
 
Newer Predictors of Preeclampsia
Newer Predictors of PreeclampsiaNewer Predictors of Preeclampsia
Newer Predictors of Preeclampsia
 
Preeclampsia
PreeclampsiaPreeclampsia
Preeclampsia
 
Induction of Labour
Induction of LabourInduction of Labour
Induction of Labour
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
 
Pph
PphPph
Pph
 

Similar to Hypertensive disorders of pregnancy.ppt

CIP.pptx
CIP.pptxCIP.pptx
CIP.pptx
Priyanka964777
 
Medical disorders in pregnancy
Medical disorders in pregnancyMedical disorders in pregnancy
Medical disorders in pregnancy
Awoke Worku
 
hellp-syndrome-–-therapeutic-challenge.ppt
hellp-syndrome-–-therapeutic-challenge.ppthellp-syndrome-–-therapeutic-challenge.ppt
hellp-syndrome-–-therapeutic-challenge.ppt
FREEDOMMARKETING
 
pre_and_eclampsia.ppt
pre_and_eclampsia.pptpre_and_eclampsia.ppt
pre_and_eclampsia.ppt
Ogunsina1
 
Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01
Krupa Meet Patel
 
htninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdfhtninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdf
SavitaHanamsagar
 
coma and convulsions in pregnancy.ppt
coma and convulsions in pregnancy.pptcoma and convulsions in pregnancy.ppt
coma and convulsions in pregnancy.ppt
ParulSinha25
 
2.maternity Abnormal pregnancy.pptx
2.maternity Abnormal pregnancy.pptx2.maternity Abnormal pregnancy.pptx
2.maternity Abnormal pregnancy.pptx
HgjUy7
 
Hypertensive in pregnancy new.pptx
Hypertensive in pregnancy new.pptxHypertensive in pregnancy new.pptx
Hypertensive in pregnancy new.pptx
NuhaAbdullah6
 
Peripartum convulsions
Peripartum convulsionsPeripartum convulsions
Peripartum convulsions
rajeev sood
 
Pih, by dr omer ajmal
Pih, by dr omer ajmalPih, by dr omer ajmal
Pih, by dr omer ajmal
Omer Ajmal
 
CME Hypertension in Pregnancy yoges edited.pptx
CME Hypertension in Pregnancy yoges edited.pptxCME Hypertension in Pregnancy yoges edited.pptx
CME Hypertension in Pregnancy yoges edited.pptx
yogeswary7
 
PRE ECLAMPSIA .pptx
PRE ECLAMPSIA .pptxPRE ECLAMPSIA .pptx
PRE ECLAMPSIA .pptx
ruth444mukami
 
Hypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmadHypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmad
Ayub Medical College
 
Presentation PRENANCY INDUCED HYPERTENSION
Presentation PRENANCY INDUCED HYPERTENSIONPresentation PRENANCY INDUCED HYPERTENSION
Presentation PRENANCY INDUCED HYPERTENSION
home
 
Pregnancy related hypertensive disorders
Pregnancy related hypertensive disordersPregnancy related hypertensive disorders
Pregnancy related hypertensive disorders
Ayub Medical College
 
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdfpregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
GichanaElvis
 
Hypertensive Dirders of Pregnancy By Dr Zahid Ullah
Hypertensive Dirders of Pregnancy By Dr Zahid UllahHypertensive Dirders of Pregnancy By Dr Zahid Ullah
Hypertensive Dirders of Pregnancy By Dr Zahid Ullah
Ayub Medical College
 
PREGNANCY WITH CONVULSIONS
PREGNANCY WITH CONVULSIONSPREGNANCY WITH CONVULSIONS
PREGNANCY WITH CONVULSIONS
drmcbansal
 
Pih
PihPih

Similar to Hypertensive disorders of pregnancy.ppt (20)

CIP.pptx
CIP.pptxCIP.pptx
CIP.pptx
 
Medical disorders in pregnancy
Medical disorders in pregnancyMedical disorders in pregnancy
Medical disorders in pregnancy
 
hellp-syndrome-–-therapeutic-challenge.ppt
hellp-syndrome-–-therapeutic-challenge.ppthellp-syndrome-–-therapeutic-challenge.ppt
hellp-syndrome-–-therapeutic-challenge.ppt
 
pre_and_eclampsia.ppt
pre_and_eclampsia.pptpre_and_eclampsia.ppt
pre_and_eclampsia.ppt
 
Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01
 
htninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdfhtninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdf
 
coma and convulsions in pregnancy.ppt
coma and convulsions in pregnancy.pptcoma and convulsions in pregnancy.ppt
coma and convulsions in pregnancy.ppt
 
2.maternity Abnormal pregnancy.pptx
2.maternity Abnormal pregnancy.pptx2.maternity Abnormal pregnancy.pptx
2.maternity Abnormal pregnancy.pptx
 
Hypertensive in pregnancy new.pptx
Hypertensive in pregnancy new.pptxHypertensive in pregnancy new.pptx
Hypertensive in pregnancy new.pptx
 
Peripartum convulsions
Peripartum convulsionsPeripartum convulsions
Peripartum convulsions
 
Pih, by dr omer ajmal
Pih, by dr omer ajmalPih, by dr omer ajmal
Pih, by dr omer ajmal
 
CME Hypertension in Pregnancy yoges edited.pptx
CME Hypertension in Pregnancy yoges edited.pptxCME Hypertension in Pregnancy yoges edited.pptx
CME Hypertension in Pregnancy yoges edited.pptx
 
PRE ECLAMPSIA .pptx
PRE ECLAMPSIA .pptxPRE ECLAMPSIA .pptx
PRE ECLAMPSIA .pptx
 
Hypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmadHypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmad
 
Presentation PRENANCY INDUCED HYPERTENSION
Presentation PRENANCY INDUCED HYPERTENSIONPresentation PRENANCY INDUCED HYPERTENSION
Presentation PRENANCY INDUCED HYPERTENSION
 
Pregnancy related hypertensive disorders
Pregnancy related hypertensive disordersPregnancy related hypertensive disorders
Pregnancy related hypertensive disorders
 
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdfpregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
pregnancyrelatedhypertensivedisorders-150322002737-conversion-gate01_2.pdf
 
Hypertensive Dirders of Pregnancy By Dr Zahid Ullah
Hypertensive Dirders of Pregnancy By Dr Zahid UllahHypertensive Dirders of Pregnancy By Dr Zahid Ullah
Hypertensive Dirders of Pregnancy By Dr Zahid Ullah
 
PREGNANCY WITH CONVULSIONS
PREGNANCY WITH CONVULSIONSPREGNANCY WITH CONVULSIONS
PREGNANCY WITH CONVULSIONS
 
Pih
PihPih
Pih
 

Recently uploaded

คำศัพท์ คำพื้นฐานการอ่าน ภาษาอังกฤษ ระดับชั้น ม.1
คำศัพท์ คำพื้นฐานการอ่าน ภาษาอังกฤษ ระดับชั้น ม.1คำศัพท์ คำพื้นฐานการอ่าน ภาษาอังกฤษ ระดับชั้น ม.1
คำศัพท์ คำพื้นฐานการอ่าน ภาษาอังกฤษ ระดับชั้น ม.1
สมใจ จันสุกสี
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Diana Rendina
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
Jyoti Chand
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
iammrhaywood
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
eBook.com.bd (প্রয়োজনীয় বাংলা বই)
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Himanshu Rai
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
TechSoup
 
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdfWalmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
TechSoup
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
Celine George
 

Recently uploaded (20)

คำศัพท์ คำพื้นฐานการอ่าน ภาษาอังกฤษ ระดับชั้น ม.1
คำศัพท์ คำพื้นฐานการอ่าน ภาษาอังกฤษ ระดับชั้น ม.1คำศัพท์ คำพื้นฐานการอ่าน ภาษาอังกฤษ ระดับชั้น ม.1
คำศัพท์ คำพื้นฐานการอ่าน ภาษาอังกฤษ ระดับชั้น ม.1
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
 
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdfWalmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
 

Hypertensive disorders of pregnancy.ppt

  • 2. 2 Introduction 1. Hypertensive disorders of pregnancy are one of the leading causes of maternal mortality. 2. Worldwide: 50,000 women die each year. 3. Jordan: 4th. Cause of maternal death after (hemorrhage, thrombo-embolism, and sepsis. (Jordan MMR 19.1 per 100000 live birth, 2007-2008)
  • 3. 3 Diagnosis of hypertension in pregnancy  A systolic BP of > 140 mmHg, a diastolic BP of > 90 mmHg, or both.  Hypertension is considered severe when BP > 160 for systolic or > 110 for diastolic.  It required at lest two determinations with at least 6 hours apart of bed rest.
  • 4. 4 How to measure BP in pregnant woman  Women should be allowed to sit quietly for 10-20 minutes before each blood pressure measurement.  Blood pressure should be measured in the sitting position, with the cuff at the level of the heart.  Korotkoff sounds I (the first sound) and V (the disappearance of sound) should be used to denote the systolic blood pressure (SBP) and DBP, respectively.  In about 5% of women, an exaggerated gap exists between the fourth (muffling) and fifth (disappearance) Korotkoff sounds, with the fifth sound approaching zero. In this setting, both the fourth and fifth sounds should be recorded (eg, 120/80/40, with sound I = 120, sound IV = 80, and sound V = 40), because the fourth sound will more closely approximate the true DBP.
  • 5. 5 Diagnosis of Protienurea in pregnancy  Proteinuria:  ≥ 300mg/24 hours urine.  ≥ +1 dipstick. (only applicable if the others are not avialables)  Urinary Protein:creatinine ratio:  At least 0.3 (each measured as mg/dl)
  • 6. 6 Classifications  Gestational hypertension.  Preeclampsia-Eclampsia.  Chronic hypertension with pregnancy.  Chronic hypertension with Superimposed preeclampsia.
  • 7. 7 Definitions  Gestational hypertension: – Hypertension for first time after 20 w, without Proteinuria. BP returns to normal before 12 weeks postpartum.  Chronic hypertension with pregnancy: – Hypertension antedates pregnancy and detected before 20 w, & lasts more than 12 weeks postpartum.
  • 8. 8 Definitions – Preeclampsia:  The development of hypertension and Proteinuria after 20 weeks.  May occur earlier in vesicular mole or multiple pregnancy.  Preeclampsia is diagnosed also in the presence of sever features even in the absence of protienurea (see next slide). – Eclampsia:  The occurrence of tonic-clonic convulsions (without any neurological disease) in a woman with pre- eclampsia.
  • 9. 9 Definitions  Superimposed pre-eclampsia: ¤ It is the new development of Proteinuria after 20 weeks gestation in a patient with chronic hypertension
  • 10. 10
  • 11. 11 Incidence of hypertensive disorders in pregnancy  Gestational hypertension occurs in around 5-6% of all pregnancies. More common in primigravida. Most cases are diagnosed after 34 weeks.  PE complicates 1-2% of all pregnancies. 4-7% of first pregnancies (1 in 4 of PIH) and 1% of subsequent pregnancies, rising to 16% with history of preeclampsia in first pregnancy.  Around 5-10% of PE cases are severe.  Approximately 1% of pregnancies are complicated by chronic hypertension and 20-25% of women with chronic hypertension develop preeclampsia during pregnancy.
  • 12. 12 Pre-eclampsia (PE): Definition: A diastolic BP > 90 mmHg, on at least two occasions after 20 weeks of gestation accompanied by significant proteinuria (> 300 mg/24h) and/or other systemic severe manifestations mentioned before.
  • 13. 13 Aetiology of PE: PE is the disease of theories: 1. Damage to the vascular endothelial cells. 2. Abnormal lipid metabolism. 3. Reduced anti-oxidant status. 4. Altered catecholamine homeostasis. 5. Abnormal dietary calcium, magnesium, or selenium. 6. Reduced production of nitric oxide. 7. Abnormal immune response to pregnancy.
  • 14. 14 Patho-physiology of PE:  Abnormal placentation is central to the pathogenesis of PE.  In PE there is reduction in the synthesis of nitric oxide and prostacyclin and increased production of endothelin and sensitivity to angiotensin. This result in to vasospasm and endothelial dysfunction, with subsequent platelet activation and micro thrombus formation. These are responsible for features of PE.
  • 15. 15 Multi-system Features Of Preeclampsia Multi-organ disease Kidney Systemic blood vessels Liver Fetus Cerebral blood vessels HELLP syndrome IUGR Eclampsia Proteinuria Hypertension
  • 16. 16 Clinical features of PE: Maternal syndrome: 1. PIH. 2. Proteinuria. 3. Generalized oedema. 4. Hyperuricaemia. 5. Increased haematocrit. 6. Thrombocytopenia & DIC. 7. Reduced antithrombin III. 8. Abnormal liver function tests. 9. Hypocalciuria. 10. Seizures, cortical blindness, retinal detachment (eclampsia). Fetal syndrome: 1. IUGR. 2. Fetal hypoxaemia.
  • 17. 17 Prevention of PE:  Aspirin: Low dose (81mg/day) increases the prostacycline to thromboxan ratio and prevent platelets aggregation. It should be used from 12 weeks of pregnancy in women at risk.  Calcium supplementation ( may reduce severity in women with low intake of calcium.  Antioxidant: vit.C or vit.E (not effective)  Restriction of dietary salt (not effective)
  • 18. 18 High risk women that need aspirin  Maternal disorders: – Chronic hypertension – Renal diseases – Diabetes – Autoimmune conditions  First pregnancy  Multiple pregnancy  Maternal BMI > 25  H/O preeclampsia  Age > 40 years
  • 19. 19 Investigations for PE:  Urinalysis.  24 h urine collection for total protein.  Renal function (urea,uric acid,s. creatinine).  Full blood count (platelets and haematocrit).  Liver function tests.  Coagulation profile if delivery is indicated.  Fetal biophysical profile and Doppler study.
  • 20. 20 Management of PE:  Diagnosis of PE requires admission for bed rest and close monitoring for mother and fetus.  If the diastolic BP is 90-95mmHg with only 1+ protein in the urine, out-patient management could be followed.  The definitive treatment for PE is delivery. But this depend on gestational age and feto- maternal well-being.
  • 21. 21 Management of PE (cont.): Antihypertensive therapy:  Treating the hypertension is mainly to reduce the maternal complications. It will not improve fetal condition. Acute treatment of severe hypertension:  Hydralazine: 5mg IV repeated every 20-30 min.  Nifedipine: 10mg orally repeated at 30 min. IV infusion can be used in severe cases.  Labetalol:10-20mg IV .  The dose can be doubled every 10 minutes if proper response is not achieved.  Magnesium Sulphate should be given in the management of all cases of severe preeclampsia to prevent eclampsia.
  • 22. 22 Indications for delivery in PE:  Term pregnancy.  Severe uncontrolled hypertension (>160/110).  Haemolysis with thrombocytopenia.  Progressive symptoms (headache, visual disturbances, epigastric pain).  Pulmonary oedema.  Renal failure with oliguria.  Eclampsia.  Fetal compromise ( abnormal biophysical profile).
  • 23. 23 Management of labour and delivery:  The mode of delivery is determined by Bishop’s score and feto-maternal well-being.  Induction of labour is commonly used, but CS is needed in large number of cases.  Fluids input and output should be monitored.  Prolonged pushing by the mother should be avoided.  Ergometrine should be avoided.  Pain relief is optimal (epidural analgesia if no signs of DIC).
  • 24. 24 Complications of severe PE: Eclampsia: Occurrence of convulsions in association with PE.  Incidence: 5 in 10 000 deliveries and 1-2% of severe PE cases.  High maternal and fetal mortality.  It can occur ante-natally, intra-partum and post-partum.  The patho-physiology is cerebral vasospasm leading to ischemia and cerebral edema.
  • 25. 25 Eclampsia: Diagnosis:  Women manifest excitability or hyperflexia prior to onset of seizure.  Tonic-clonic convulsions with small period of coma.  Prolonged coma mains CVA.
  • 26. 26 Management of eclampsia:  During seizure: Maintain airway, Administer oxygen and avoid supine hypotension.  Anticonvulsant therapy: 1. Magnesium sulphate 4-6 g IV followed by a maintenance infusion of 1-2 g / h. 2. Diazepam 20mg IV followed by a maintenance infusion as required. 3. Phynenton  Anticonvulsant should be continued for at least 24 h after the last convulsion.  CS is indicated unless the mother is in active labour.
  • 27. 27 Magnesium Sulfate (MgSO4):  It can be given IV or IM or SC – The therapeutic level is 4-7mEq/L. – The total dose of MgSO4 should not exceed 24 gms in 24 hours .  The dose of MgSO4 is monitored by:  Preserved patellar reflex. (7-10 mEq/L)  Respiratory rate >16/min. (10-13 mEq/L)  Urine output >100ml/4hours. (15-25 mEq/L)  Serum Mg++ level.  Is stopped 24 hours after delivery.  Antidote is ca gluconate
  • 28. 28 Complications of severe PE: HELLP syndrome: Occurs in the absence of hypertension. H: haemolysis. EL: elevated liver enzymes. LP: low platelet count.  Present with epigastric pain, tender liver, nausea & vomiting.  Headache and arterial hypertension.  Carries high maternal (acute renal failure & pulmonary odema) and fetal mortality.  Treatment similar to eclampia & DIC. Platelet transfusion and cortico-steroids are necessary.  Delivery is the treatment of choice.
  • 29. 29 Chronic hypertension in pregnancy Causes of CHT: 1. Essential hypertension. 2. Renal diseases (glomerulonephritis, polycystic disease, diabetic nephropathy, renal artery stenosis). 3. Collagen vascular diseases ( systemic lupus erythematosus, scleroderma). 4. Coarctation of the aorta. 5. Phaeochromocytoma.
  • 30. 30 Chronic hypertension in pregnancy  The main concern that one third of these women will develop superimposed PIH. Risk factors for preeclampsia in CHT: 1. Renal disease. 2. Maternal age > 40 years. 3. Diabetes. 4. SLE. 5. Coarctation of the aorta. 6. BP > 160/100 mmHg in early pregnancy.
  • 31. 31 Chronic hypertension in pregnancy Feto-Maternal risks: 1. Eclampsia. 2. Abruptio-placenta. 3. Heart failure. 4. Intracerebral haemorrhage. 5. IUGR.
  • 32. 32 Long-term treatment of hypertension This is used mainly in CHD.  Methyldopa is the most common in use (least side effects). 1-2 g / day in three divided doses.  Nifedipine 40 mg / day in two divided doses.  Labetolol and Hydralazine can also be used.  ACE inhibitors, Angiotensin II blocker, and Chlorothiazide should be avoided because of teratogenic effect.
  • 33. 33 Chronic hypertension in pregnancy Management:  Investigations should be performed to diagnose the cause of hypertension.  If the woman is on antihypertensive drugs, she should continue on it, except for angiotensin converting enzyme inhibitors (captoprel) because of risk of fetal damage. Care should be taken not to excessively lower the BP as this may affect the fetal healthy.  Maternal and fetal well-being should be monitored through the pregnancy.
  • 34. 34 Chronic hypertension in pregnancy Management (cont.):  In severe cases admission is needed.  The obstetric management is similar to that of preeclampsia.  Timing the delivery must be individualized according to the feto-maternal well-being.  Induction of labour or CS should be selected according to the case.
  • 35. 35